Due to a new federal holiday, the US Centers for Disease Control and Prevention (CDC) had to postpone an emergency meeting on myocarditis after a COVID-19 vaccine was detected in Americans, mainly weakness occurs in young subjects.
CDC USA headquarters in Atlanta. (Photo: Jim Gathany/Wikimedia/Muff)
President Joe Biden signed a bill on June 17, making June 19 a new federal holiday. Shortly after, the CDC said its meeting scheduled for June 18 “is being rescheduled due to a new National Independence Day June 19.”
The CDC said that the emergency meeting announced last week will now be rescheduled to an online meeting from June 23 to June 25.
CDC officials plan to present to the agency’s vaccine advisory board updated information about myocarditis and pericarditis occurring in people who have received the COVID-19 vaccine.
A CDC official told members of the Food and Drug Administration’s (FDA) vaccine advisory committee on June 10 that there were more than 800 reports of myocarditis following vaccination. The vaccine has been submitted to the Vaccine Adverse Event Reporting System (VAERS).
Many people have voiced their criticism of the CDC’s move. “This is a big mistake, in my opinion. The CDC director should keep the meeting on schedule,” Dr. Walid Gellad, a professor of medicine at the University of Pittsburgh School of Medicine, said on Twitter. “There are very important cognitive issues to consider here. Many people are concerned about these ongoing side effects.”
On June 17, Dr Rochelle Walensky, director of the US CDC, told reporters during a meeting that the CDC’s vaccine advisory panel would meet in the following days to review data on reports. There have been reports of myocarditis and pericarditis following vaccination.
“These cases are very rare, and the vast majority have resolved completely through rest and supportive care. CDC will detail the more than 300 confirmed cases of myocarditis and pericarditis reported to CDC and FDA among the more than 20 million vaccinated adolescents in the United States,” she said.
The advisory panel “will listen to analyzes of the risks and benefits associated with COVID-19 vaccination versus potential rare adverse events across all age groups,” she added later. .
Some health experts think the advisory panel may recommend that young people not get a COVID-19 vaccine built on mRNA technology. Both Pfizer and Moderna use this mRNA technology.
“Looking at the data, I think one might just recommend a single dose of the mRNA vaccine for young people, give up the mRNA vaccine or use the vector vaccine,” said Dr. Professor of medicine in the Department of Infectious Diseases at Emory University School of Medicine, said on Twitter recently.